One World Products, Inc. OWPC

Q3 FY2025 · ended Sep 30, 2025 · Revenue $49,966, +3193.7% YoY · Filed Jan 2, 2026

One World Products, Inc. (OWPC) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q3 of fiscal 2025, the quarter ended Sep 30, 2025, it reported revenue of $49,966 and net income of $5.3 million.

Revenue
$49,966
+3193.7% vs year-ago quarter
Net income
$5.27M
+816.8% vs year-ago quarter
Operating cash flow
$-144,996
+48.3% vs year-ago quarter
Free cash flow
$-150,893
EPS
$0.04
+540.0% vs year-ago quarter
Dividend per share
$0.00
Shares outstanding
120.11M
+13.4% vs year-ago quarter
Net cash
—
Operating margin
-1930.5%
TTM

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OWPC (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Troy, MI
SEC filer status
, Emerging growth company
SEC CIK
1622244
Former names
One World Pharma, Inc. (until Nov 30, 2021); PUNTO GROUP, CORP. (until Jan 8, 2019)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Revenue
$49,966
$282
$1,371
$1,810
$1,517
Operating income
-$377,140
-$171,069
-$125,900
-$349,651
-$371,631
Net income
$5.3M
-$265,916
-$255,666
-$634,332
-$734,599
Diluted EPS
$0.04
-$0.00
$0.00
-$0.01
-$0.01
Operating cash flow
-$144,996
-$396,746
-$52,095
-$111,369
-$280,561
Total assets
$6.6M
$226,220
$24,663
$68,300
$275,183
Total liabilities
$7.1M
$5.9M
$5.5M
$5.3M
$5.4M
Stockholders' equity
-$5.2M
-$10.4M
-$10.2M
-$9.9M
-$9.8M
Cash and investments
$168,620
$13,615
$361
$42,456
$361

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 27, 2026 Oct 27, 2026
8-K Current report
Officer or director change
Jul 27, 2026 Jul 23, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 27, 2026
10-Q Quarterly report Jan 2, 2026 Sep 30, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 21, 2025 Oct 21, 2025
8-K Current report
Officer or director change
Sep 30, 2025 Sep 29, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.